Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265061 | 12726506 | 1 | I | 20160830 | 20160908 | 20160908 | EXP | JP-SA-2016SA161478 | AVENTIS | KAWASUMI H, GONO T, TANAKA E, KANEKO H, KAWAGUCHI Y, YAMANAKA H. CLINICAL CHARACTERISTICS AND CYTOKINE PROFILES OF ORGANIZING PNEUMONIA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH OR WITHOUT BIOLOGICS. J RHEUMATOL. 2016;43(4):738-44. DOI:10.3899/JRHEUM.151019 | 41.00 | YR | A | F | Y | 0.00000 | 20160908 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265061 | 12726506 | 1 | PS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | Y | N | UNK | 20905 | /wk | |||||||
| 127265061 | 12726506 | 2 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | Y | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127265061 | 12726506 | 1 | Rheumatoid arthritis |
| 127265061 | 12726506 | 2 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127265061 | 12726506 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127265061 | 12726506 | Cough | |
| 127265061 | 12726506 | Fatigue | |
| 127265061 | 12726506 | Organising pneumonia | |
| 127265061 | 12726506 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |